Found: 13
Select item for more details and to access through your institution.
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
- Published in:
- Human Genomics, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s40246-024-00579-8
- By:
- Publication type:
- Article
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0127-5
- By:
- Publication type:
- Article
Posaconazole‐ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 2, p. 557, doi. 10.1111/bcp.15932
- By:
- Publication type:
- Article
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2907, doi. 10.3390/cancers13122907
- By:
- Publication type:
- Article
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 1, p. 217, doi. 10.1007/s10549-017-4388-0
- By:
- Publication type:
- Article
Uptake of 4-borono-2-[<sup>18</sup>F]fluoro- L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 1, p. 87, doi. 10.1007/s00259-006-0154-y
- By:
- Publication type:
- Article
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 71, doi. 10.1002/cpt.3067
- By:
- Publication type:
- Article
Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 10, p. 2692, doi. 10.1002/ijc.32309
- By:
- Publication type:
- Article
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 12, p. 2760, doi. 10.1002/ijc.30394
- By:
- Publication type:
- Article
RAD51B in Familial Breast Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0153788
- By:
- Publication type:
- Article
Screening of HELQ in breast and ovarian cancer families.
- Published in:
- Familial Cancer, 2016, v. 15, n. 1, p. 19, doi. 10.1007/s10689-015-9838-4
- By:
- Publication type:
- Article
CYP2C19 loss‐of‐function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 10, p. 2010, doi. 10.1111/cts.13608
- By:
- Publication type:
- Article
NTHL1 is a recessive cancer susceptibility gene.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47441-w
- By:
- Publication type:
- Article